Key result
Heterozygous FH is linked to early subclinical atherosclerosis, beginning at age ~17 in males.
Why the study?
Data on the appropriate timing and impact of atherosclerosis assessment in patients with heterozygous familial hypercholesterolemia are limited.
Does triple assessment of atherosclerosis help in risk stratification for coronary heart disease events in patients with heterozygous familial hypercholesterolemia?
Cohort (n=622)
No
Does triple assessment of atherosclerosis help in risk stratification for coronary heart disease events in patients with heterozygous familial hypercholesterolemia?
Answers are grounded in this paper and cite their sources.
Triple assessment of carotid plaque, coronary plaque, and CAC helps in risk stratification and identifies the early onset of atherosclerosis in patients with heterozygous familial hypercholesterolemia.
BACKGROUND: Data on the appropriate timing and impact of atherosclerosis assessment in patients with heterozygous familial hypercholesterolemia (HeFH) are limited. OBJECTIVES: The authors aimed to determine when atherosclerotic changes occur and the utility of triple assessments of carotid plaque, coronary plaque, and coronary artery calcium (CAC) in patients with HeFH. METHODS: Data from patients with HeFH in the primary prevention setting admitted to Kanazawa University Hospital between 2000 and 2020 who underwent triple atherosclerosis assessment and were followed up were retrospectively reviewed (n = 622, male = 306, mean age = 54 ± 13 years). Risk factors for coronary heart disease events were determined using the Cox proportional hazard model. Carotid plaque, coronary plaque, and CAC scores were plotted against age. Significant differences of cardiovascular events were observed among the groups according to atherosclerotic burden. CONCLUSIONS: On average, carotid plaque, coronary plaque, and CAC may develop at ages 17, 26, and 31 years in male patients and 30, 36, and 40 years in female patients with HeFH, respectively, based on regression equations. Furthermore, triple assessments help in risk stratification.
No takes yet. Share an insight, caveat, or question.
Tada et al. (2025) conducted a cohort in Heterozygous Familial Hypercholesterolemia (n=622). Triple assessments of atherosclerosis (carotid plaque, coronary plaque, and coronary artery calcium) was evaluated on Cardiovascular events. Triple assessments of atherosclerosis revealed that carotid plaque, coronary plaque, and coronary artery calcium may develop at ages 17, 26, and 31 in males and 30, 36, and 40 in females with HeFH.
Synapse has enriched 10 related papers. Consider them for comparative context: